HCINAP is a novel regulator of ribosomal protein-HDM2-p53 pathway by controlling NEDDylation of ribosomal protein S14

Oncogene

Volumn 33, Issue 2, 2014, Pages 246-254

  Zhang, J ^a   Bai, D ^a   Ma, X ^a   Guan, J ^a   Zheng, X ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

hCINAP; HDM2; NEDDylation; p53; RPS14

Indexed keywords

HUMAN COILIN INTERACTING NUCLEAR ATPASE PROTEIN; MEMBRANE PROTEIN; NEDD8 PROTEIN; PROTEIN MDM2; PROTEIN P53; RECOMBINANT PROTEIN; RIBOSOME PROTEIN; RIBOSOME PROTEIN S14; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HCT116; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOLECULAR DYNAMICS; NEDDYLATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; UBIQUITINATION;

ENDOPEPTIDASES; HCT116 CELLS; HUMANS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RIBOSOMAL PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES; UBIQUITINS;

EID: 84891955718     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.560     Document Type: Article

References (39)

1. Dey A, Lane DP, Verma CS. Modulating the p53 pathway. Semin Cancer Biol 2010; 20: 3-9
2. Lane D, Levine A. p53 Research: The past thirty years and the next thirty years. Cold Spring Harb Perspect Biol 2010; 2: A000893
3. Moll UM, Petrenko O. The MDM2-p53 interaction. Mol Cancer Res 2003; 1: 1001-1008
4. Zhang Y, Lu H. Signaling to p53: Ribosomal proteins find their way. Cancer Cell 2009; 16: 369-377
5. Narla A, Ebert BL. Ribosomopathies: Human disorders of ribosome dysfunction. Blood 2010; 115: 3196-3205
6. Pan W, Issaq S, Zhang Y. The in vivo role of the RP-Mdm2-p53 pathway in signaling oncogenic stress induced by pRb inactivation and Ras overexpression. PLoS One 2011; 6: E21625
7. Miliani de Marval PL, Zhang Y. The RP-Mdm2-p53 pathway and tumorigenesis. Oncotarget 2011; 2: 234-238
8. Zhou X, Hao Q, Liao J, Zhang Q, Lu H. Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress. Oncogene 2012; 63: 1-9
9. Zhang Y, Wang J, Yuan Y, Zhang W, Guan W, Wu Z et al. Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26. Nucleic Acids Res 2010; 38: 6544-6554
10. Xiong X, Zhao Y, He H, Sun Y. Ribosomal protein S27-like and S27 interplay with p53-MDM2 axis as a target, a substrate and a regulator. Oncogene 2010; 30: 1798-1811
11. Zhu Y, Poyurovsky MV, Li Y, Biderman L, Stahl J, Jacq X et al. Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell 2009; 35: 316-326
12. Yadavilli S, Mayo LD, Higgins M, Lain S, Hegde V, Deutsch WA. Ribosomal protein S3: A multi-functional protein that interacts with both p53 and MDM2 through its KH domain. DNA Repair 2009; 8: 1215-1224
13. Chen D, Zhang Z, Li M, Wang W, Li Y, Rayburn ER et al. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: Binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene 2007; 26: 5029-5037
14. Dai MS, Zeng SX, Jin Y, Sun XX, David L, Lu H. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 2004; 24: 7654-7668
15. Dai MS, Lu H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem 2004; 279: 44475-44482
16. Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA et al. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 2003; 23: 8902-8912
17. Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon M, Vousden KH. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003; 3: 577-587
18. Xirodimas DP, Sundqvist A, Nakamura A, Shen L, Botting C, Hay RT. Ribosomal proteins are targets for the NEDD8 pathway. EMBO Rep 2008; 9: 280-286
19. Sundqvist A, Liu G, Mirsaliotis A, Xirodimas DP. Regulation of nucleolar signalling to p53 through NEDDylation of L11. EMBO Rep 2009; 10: 1132-1139
20. Meng G, Zhai R, Liu B, Zheng X. Identification of a novel nuclear-localized adenylate kinase from Drosophila melanogaster. Biochemistry 2008; 73: 38-43
21. Zhai R, Meng G, Zhao Y, Liu B, Zhang G, Zheng X. A novel nuclear-localized protein with special adenylate kinase properties from Caenorhabditis elegans. FEBS Lett 2006; 580: 3811-3817
22. Granneman S, Nandineni MR, Baserga SJ. The putative NTPase Fap7 mediates cytoplasmic 20S pre-rRNA processing through a direct interaction with Rps14. Mol Cell Biol 2005; 25: 10352-10364
23. Juhnke H, Charizanis C, Latifi F, Krems B, Entian KD. The essential protein fap7 is involved in the oxidative stress response of Saccharomyces cerevisiae. Mol Microbiol 2000; 35: 936-948
24. Takahashi T, Yano T, Zhu J, Hwang GW, Naganuma A. Overexpression of FAP7, MIG3, TMA19, or YLR392c confers resistance to arsenite on Saccharomyces cerevisiae. J Toxicol Sci 2010; 35: 945-946
25. Zhang J, Zhang F, Zheng X. Depletion of hCINAP by RNA interference causes defects in Cajal body formation, histone transcription, and cell viability. Cell Mol Life Sci 2010; 67: 1907-1918
26. Santama N, Ogg SC, Malekkou A, Zographos SE, Weis K, Lamond AI. Characterization of hCINAP, a novel coilin-interacting protein encoded by a transcript from the transcription factor TAFIID32 locus. J Biol Chem 2005; 280: 36429-36441
27. Malekkou A, Lederer CW, Lamond AI, Santama N. The nuclear ATPase/adenylate kinase hCINAP is recruited to perinucleolar caps generated upon RNA pol.II inhibition. FEBS Lett 2010; 584: 4559-4564
28. Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N et al. Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature 2008; 451: 335-339
29. Warner JR, McIntosh KB. How common are extraribosomal functions of ribosomal proteins? Mol Cell 2009; 34: 3-11
30. Deisenroth C, Zhang Y. Ribosome biogenesis surveillance: Probing the ribosomal protein-Mdm2-p53 pathway. Oncogene 2010; 29: 4253-4260
31. Dutt S, Narla A, Lin K, Mullally A, Abayasekara N, Megerdichian C et al. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 2011; 117: 2567-2576
32. Barlow JL, Drynan LF, Hewett DR, Holmes LR, Lorenzo-Abalde S, Lane AL et al. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome. Nat Med 2010; 16: 59-66
33. Fumagalli S, Ivanenkov VV, Teng T, Thomas G. Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes Dev 2012; 26: 1028-1040
34. Boyd SD, Tsai KY, Jacks T. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat Cell Biol 2000; 2: 563-568
35. Ha BH, Kim EE. Structures of proteases for ubiqutin and ubiquitin-like modifiers. BMB Rep 2008; 41: 435-443
36. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408: 307-310
37. Deisenroth C, Zhang Y. The Ribosomal Protein-Mdm2-p53 Pathway and Energy Metabolism: Bridging the Gap between Feast and Famine. Genes Cancer 2011; 2: 392-403
38. Sasaki M, Kawahara K, Nishio M, Mimori K, Kogo R, Hamada K et al. Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Nat Med 2011; 17: 944-951
39. Xirodimas DP, Saville MK, Bourdon JC, Hay RT, Lane DP. Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell 2004; 118: 83-97